Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eisai's Halavan misses endpoints in Phase III trial
Eisai's Halavan misses endpoints in Phase III trial
Eisai's Halavan misses endpoints in Phase III trial
Submitted by
admin
on July 11, 2012 - 10:06am
Source:
Pharma Times, UK
News Tags:
Eisai
Halavan
Xeloda
breast cancer
Headline:
Eisai's Halavan misses endpoints in Phase III trial
Do Not Allow Advertisers to Use My Personal information
